A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review

Objectives: The coronavirus disease 2019 (COVID-19) pandemic has led to significant morbidity and mortality. Although COVID-19 vaccination is available, therapeutic options are still needed. The goal of the present manuscript is to report on a treatment strategy used in a naturopathic medical practi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Melissa S. Barber, Richard Barrett, Ryan D. Bradley, Erin Walker
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/bfd8079fb50d43aa817d5b60a0157f07
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bfd8079fb50d43aa817d5b60a0157f07
record_format dspace
spelling oai:doaj.org-article:bfd8079fb50d43aa817d5b60a0157f072021-11-14T04:30:48ZA naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review0965-229910.1016/j.ctim.2021.102788https://doaj.org/article/bfd8079fb50d43aa817d5b60a0157f072021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0965229921001291https://doaj.org/toc/0965-2299Objectives: The coronavirus disease 2019 (COVID-19) pandemic has led to significant morbidity and mortality. Although COVID-19 vaccination is available, therapeutic options are still needed. The goal of the present manuscript is to report on a treatment strategy used in a naturopathic medical practice for mild and moderate COVID-19. Design: A retrospective chart review was conducted of 30 consecutive patients diagnosed with mild and moderate COVID-19 who were provided multi-nutrient, herbal, and probiotic treatment in a rural, out-patient, naturopathic primary care setting. Main outcomes measures: The primary outcome was treatment safety; secondary outcomes included changes in symptoms, progression to severe COVID-19, incidence of long COVID, and recovery time. Results: No side effects or adverse events were reported from treatment and all patients experienced resolution of symptoms presumed to be associated with COVID-19 infection. One patient who had been ill for 28 days prior to presentation was hospitalized. Five patients had an illness duration of more than one month. Time to treatment was correlated with duration of illness post-treatment (r = 0.63, p < 0.001) and more symptoms at presentation was correlated with a longer duration of illness (r = 0.52, p < 0.01). Conclusions: In this retrospective chart review, a multi-nutrient, herbal, and probiotic therapeutic approach for mild and moderate COVID-19 appeared to be well-tolerated. Delay in seeking treatment after symptom onset, as well as more symptoms at presentation, were correlated with a longer duration of illness. This treatment strategy may have clinical benefit, warranting prospective clinical trials with confirmed COVID-19 cases.Melissa S. BarberRichard BarrettRyan D. BradleyErin WalkerElsevierarticleCOVID-19SARS-CoV-2Herbal medicinePhytotherapyVitaminsMineralsOther systems of medicineRZ201-999ENComplementary Therapies in Medicine, Vol 63, Iss , Pp 102788- (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
SARS-CoV-2
Herbal medicine
Phytotherapy
Vitamins
Minerals
Other systems of medicine
RZ201-999
spellingShingle COVID-19
SARS-CoV-2
Herbal medicine
Phytotherapy
Vitamins
Minerals
Other systems of medicine
RZ201-999
Melissa S. Barber
Richard Barrett
Ryan D. Bradley
Erin Walker
A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review
description Objectives: The coronavirus disease 2019 (COVID-19) pandemic has led to significant morbidity and mortality. Although COVID-19 vaccination is available, therapeutic options are still needed. The goal of the present manuscript is to report on a treatment strategy used in a naturopathic medical practice for mild and moderate COVID-19. Design: A retrospective chart review was conducted of 30 consecutive patients diagnosed with mild and moderate COVID-19 who were provided multi-nutrient, herbal, and probiotic treatment in a rural, out-patient, naturopathic primary care setting. Main outcomes measures: The primary outcome was treatment safety; secondary outcomes included changes in symptoms, progression to severe COVID-19, incidence of long COVID, and recovery time. Results: No side effects or adverse events were reported from treatment and all patients experienced resolution of symptoms presumed to be associated with COVID-19 infection. One patient who had been ill for 28 days prior to presentation was hospitalized. Five patients had an illness duration of more than one month. Time to treatment was correlated with duration of illness post-treatment (r = 0.63, p < 0.001) and more symptoms at presentation was correlated with a longer duration of illness (r = 0.52, p < 0.01). Conclusions: In this retrospective chart review, a multi-nutrient, herbal, and probiotic therapeutic approach for mild and moderate COVID-19 appeared to be well-tolerated. Delay in seeking treatment after symptom onset, as well as more symptoms at presentation, were correlated with a longer duration of illness. This treatment strategy may have clinical benefit, warranting prospective clinical trials with confirmed COVID-19 cases.
format article
author Melissa S. Barber
Richard Barrett
Ryan D. Bradley
Erin Walker
author_facet Melissa S. Barber
Richard Barrett
Ryan D. Bradley
Erin Walker
author_sort Melissa S. Barber
title A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review
title_short A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review
title_full A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review
title_fullStr A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review
title_full_unstemmed A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review
title_sort naturopathic treatment approach for mild and moderate covid-19: a retrospective chart review
publisher Elsevier
publishDate 2021
url https://doaj.org/article/bfd8079fb50d43aa817d5b60a0157f07
work_keys_str_mv AT melissasbarber anaturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview
AT richardbarrett anaturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview
AT ryandbradley anaturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview
AT erinwalker anaturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview
AT melissasbarber naturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview
AT richardbarrett naturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview
AT ryandbradley naturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview
AT erinwalker naturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview
_version_ 1718429983466061824